South Africa has one of the highest burdens of Tuberculosis (TB) and (Drug Resistant) DR-TB in the world, with around 20,000 people diagnosed with DR-TB in 2015. Some of the country’s highest rates of DR-TB exist in Khayelitsha in the Western Cape. Médecins Sans Frontierès (MSF) runs a strengthened regimen programme in the informal township, which incorporates new drugs into treatment regimens for DR-TB patients, including the drugs delamanid and bedaquiline.